Projects per year
Aquaglyceroporin-2 is a known determinant of melarsoprol-pentamidine cross-resistance in Trypanosoma brucei brucei laboratory strains. Recently, chimerization at the AQP2-AQP3 tandem locus was described from melarsoprol-pentamidine cross-resistant Trypanosoma brucei gambiense isolates from sleeping sickness patients in the Democratic Republic of the Congo. Here, we demonstrate that reintroduction of wild-type AQP2 into one of these isolates fully restores drug susceptibility while expression of the chimeric AQP2/3 gene in aqp2-aqp3 null T. b. brucei does not. This proves that AQP2-AQP3 chimerization is the cause of melarsoprol-pentamidine cross-resistance in the T. b. gambiense isolates.
|Number of pages||4|
|Journal||International Journal for Parasitology: Drugs and Drug Resistance|
|Publication status||Published - Aug 2015|
- Drug resistance
- Human African trypanosomiasis
- Reverse genetics
- Sleeping sickness
- Trypanosoma brucei gambiense
ASJC Scopus subject areas
- Infectious Diseases
- Pharmacology (medical)
FingerprintDive into the research topics of 'Chimerization at the AQP2-AQP3 locus is the genetic basis of melarsoprol-pentamidine cross-resistance in clinical Trypanosoma brucei gambiense isolates'. Together they form a unique fingerprint.
- 2 Finished
Melarsoprol-Pentamidine Cross Resistance in African Trypanosomes.
28/10/13 → 27/10/16
High-Throughput Decoding of Virulence Mechanisms in African Trypanosomes (Senior Investigator Award)
1/09/13 → 29/02/20